Literature DB >> 31282877

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone.

Ginés Ávila-Pérez1, Jun-Gyu Park1, Aitor Nogales1, Fernando Almazán2, Luis Martínez-Sobrido3.   

Abstract

The association of Zika virus (ZIKV) infection with neurological complications during the recent worldwide outbreak and the lack of approved vaccines and/or antivirals have underscored the urgent need to develop ZIKV reverse genetic systems to facilitate the study of ZIKV biology and the development of therapeutic and/or prophylactic approaches. However, like with other flaviviruses, the generation of ZIKV full-length infectious cDNA clones has been hampered due to the toxicity of viral sequences during its amplification in bacteria. To overcome this problem, we have developed a nontraditional approach based on the use of bacterial artificial chromosomes (BACs). Using this approach, the full-length cDNA copy of the ZIKV strain Rio Grande do Norte Natal (ZIKV-RGN) is generated from four synthetic DNA fragments and assembled into the single-copy pBeloBAC11 plasmid under the control of the human cytomegalovirus (CMV) immediate-early promoter. The assembled BAC cDNA clone is stable during propagation in bacteria, and infectious recombinant (r)ZIKV is recovered in Vero cells after transfection of the BAC cDNA clone. The protocol described here provides a powerful technique for the generation of infectious clones of flaviviruses, including ZIKV, and other positive-strand RNA viruses, particularly those with large genomes that have stability problems during bacterial propagation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31282877     DOI: 10.3791/59537

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  7 in total

1.  Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.

Authors:  Chengjin Ye; Kevin Chiem; Jun-Gyu Park; Jesus A Silvas; Desarey Morales Vasquez; Julien Sourimant; Michelle J Lin; Alexander L Greninger; Richard K Plemper; Jordi B Torrelles; James J Kobie; Mark R Walter; Juan Carlos de la Torre; Luis Martinez-Sobrido
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 12.779

2.  A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo.

Authors:  Kevin Chiem; Desarey Morales Vasquez; Jesus A Silvas; Jun-Gyu Park; Michael S Piepenbrink; Julien Sourimant; Michelle J Lin; Alexander L Greninger; Richard K Plemper; Jordi B Torrelles; Mark R Walter; Juan C de la Torre; James K Kobie; Chengjin Ye; Luis Martinez-Sobrido
Journal:  J Virol       Date:  2021-09-08       Impact factor: 6.549

3.  Construction of an infectious clone of Zika virus stably expressing an EGFP marker in a eukaryotic expression system.

Authors:  Jing Gao; Jiayi Chen; Weizhi Lu; Jintai Cai; Linjuan Shi; Wei Zhao; Bao Zhang
Journal:  Virol J       Date:  2021-07-19       Impact factor: 4.099

4.  The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles.

Authors:  Chien-Yi Lu; Chen-Sheng Lin; Hsueh-Chou Lai; Ya-Wen Yu; Chih-Yi Liao; Wen-Chi Su; Bo-Han Ko; Young-Sheng Chang; Su-Hua Huang; Cheng-Wen Lin
Journal:  Viruses       Date:  2019-10-31       Impact factor: 5.048

5.  Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.

Authors:  Kevin Chiem; Chengjin Ye; Luis Martinez-Sobrido
Journal:  Curr Protoc Microbiol       Date:  2020-12

6.  Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.

Authors:  Kevin Chiem; Desarey Morales Vasquez; Jun-Gyu Park; Roy Neal Platt; Tim Anderson; Mark R Walter; James J Kobie; Chengjin Ye; Luis Martinez-Sobrido
Journal:  J Virol       Date:  2021-01-11       Impact factor: 5.103

7.  Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.

Authors:  Chengjin Ye; Kevin Chiem; Jun-Gyu Park; Fatai Oladunni; Roy Nelson Platt; Tim Anderson; Fernando Almazan; Juan Carlos de la Torre; Luis Martinez-Sobrido
Journal:  mBio       Date:  2020-09-25       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.